Disclosure of interest: Xiaoqing Jiang, Zixiao Li, Yongjun Wang:nothing to disclose Poster Session I - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P413 - ESOC25-196 INVESTIGATING CARDIOVASCULAR RISK AS A MODERATOR OF THE RELATIONSHIP BETWEEN BLOOD-BASED DEMENTIA BIOMARKERS AND COGNITIVE IMPAIRMENT A CROSS-SECTIONAL ANALYSIS OF DATA FROM THE BIO-HERMES STUDY Angelina Kancheva 1 , Donald Lyall 2 , Terence J Quinn 3 1 School of Cardiovascular & Metabolic Health, University of Glasgow, University of Edinburgh, Glasgow, United Kingdom, 2 School of Health & Wellbeing, University of Glasgow, Glasgow, United Kingdom, 3 School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, United Kingdom Background and Aims: Blood-based biomarkers may enhance diagnosis and prognosis of Alzheimers disease (AD) and other dementias
Freeze-thaw cycles destroy peptides
Peptide Therapy in Denver for Whole-Body Wellness At Balanced Healthcare, peptide therapy in Denver takes an evidence-informed approach to whole-body wellness
According to a 2007 review published in the Annals of Hematology, both iron overload and iron-deficiency anemia can increase the risk of thrombosis and related cardiac events ( 5 )
The Chinese development and marketing of efgartigimod are conducted in partnership with Zai Lab [244]